Assembly Biosciences, Inc. (NASDAQ: ASMB) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Assembly Biosciences, Inc. (NASDAQ: ASMB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Assembly Biosciences, Inc. (NASDAQ: ASMB) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Assembly Biosciences Announces Effective Date of Reverse Stock Split [Yahoo! Finance]